GENEVA, July 2 -- ELI LILLY AND COMPANY filed a patent application (US2025/059766) for “PYY ANALOGUE IN COMBINATION WITH AN INCRETIN FOR USE IN THE TREATMENT OF OBESITY OR AN OBESITY-RELATED DISEASE OR DISORDER”. With publication no. WO/2026/136304, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/17
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....